XML 48 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statement of Changes in Equity Statement - CAD ($)
$ in Millions
Total
Equity attributable to owners of parent [member]
Common shares
Contributed surplus
Accumulated other comprehensive income
Retained earnings
Non-controlling interests
Number of shares (in shares) at Mar. 31, 2016     269,634,816        
Balances, beginning of year at Mar. 31, 2016 $ 1,940.3 $ 1,888.7 $ 601.7 $ 18.3 $ 220.7 $ 1,048.0 $ 51.6
Net income 256.6 251.5       251.5 5.1
Comprehensive income [abstract]              
Foreign currency translation (31.8) (31.4)     (31.4)   (0.4)
Net change in cash flow hedges 11.3 11.3     11.3    
Net change in available-for-sale financial instruments (0.2) (0.2)     (0.2)    
Share in the other comprehensive income of equity accounted investees (6.7) (6.7)     (6.7)    
Defined benefit plan remeasurements 13.5 13.5       13.5  
Total comprehensive (loss) income 242.7 238.0     (27.0) 265.0 4.7
Stock options exercised (in shares)     1,029,725        
Stock options exercised 12.6 12.6 $ 12.6        
Optional cash purchase (in shares)     2,563        
Optional cash purchase 0.1 0.1 $ 0.1        
Common shares repurchased and cancelled (in shares)     (2,490,900)        
Common shares repurchased and cancelled (41.7) (41.7) $ (5.6)     (36.1)  
Transfer upon exercise of stock options     $ 2.6 (2.6)      
Share-based payments 3.7 3.7   3.7      
Additions to non-controlling interests 3.9           3.9
Stock dividends (in shares)     221,020        
Stock dividends     $ 4.0     (4.0)  
Cash dividends (80.6) (80.6)       (80.6)  
Number of shares (in shares) at Mar. 31, 2017     268,397,224        
Balances, end of year at Mar. 31, 2017 2,081.0 2,020.8 $ 615.4 19.4 193.7 1,192.3 60.2
Net income 355.7 347.0       347.0 8.7
Comprehensive income [abstract]              
Foreign currency translation 80.5 81.7     81.7   (1.2)
Net change in cash flow hedges (0.5) (0.5)     (0.5)    
Net change in available-for-sale financial instruments 0.1 0.1     0.1    
Share in the other comprehensive income of equity accounted investees (12.7) (12.7)     (12.7)    
Defined benefit plan remeasurements (24.1) (24.1)       (24.1)  
Total comprehensive (loss) income 399.0 391.5     68.6 322.9 7.5
Stock options exercised (in shares)     1,246,575        
Stock options exercised 15.7 15.7 $ 15.7        
Optional cash purchase (in shares)     1,967        
Common shares repurchased and cancelled (in shares)     (2,081,200)        
Common shares repurchased and cancelled (44.8) (44.8) $ (4.9)     (39.9)  
Transfer upon exercise of stock options     $ 3.0 (3.0)      
Share-based payments 4.9 4.9   4.9      
Additions to non-controlling interests 3.3           3.3
Dividends to non-controlling interests (2.6)           (2.6)
Stock dividends (in shares)     173,964        
Stock dividends     $ 4.0     (4.0)  
Cash dividends (89.9) (89.9)       (89.9)  
Number of shares (in shares) at Mar. 31, 2018     267,738,530        
Balances, end of year at Mar. 31, 2018 $ 2,366.6 $ 2,298.2 $ 633.2 $ 21.3 $ 262.3 $ 1,381.4 $ 68.4